These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15950638)

  • 1. Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome.
    d'Alva CB; Serafini P; Motta E; Kohek MB; Latronico AC; Mendonca BB
    Fertil Steril; 2005 Jun; 83(6):1695-9. PubMed ID: 15950638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome.
    Kerkelä E; Skottman H; Friden B; Bjuresten K; Kere J; Hovatta O
    Fertil Steril; 2007 Mar; 87(3):603-6. PubMed ID: 17074323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome.
    Binder H; Dittrich R; Hager I; Müller A; Oeser S; Beckmann MW; Hamori M; Fasching PA; Strick R
    Reproduction; 2008 Jan; 135(1):107-16. PubMed ID: 18159088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS).
    Morón FJ; de Castro F; Royo JL; Montoro L; Mira E; Sáez ME; Real LM; González A; Mañes S; Ruiz A
    Pharmacogenet Genomics; 2006 Jul; 16(7):485-95. PubMed ID: 16788381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
    Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1255-8. PubMed ID: 15080154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
    Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1255-8. PubMed ID: 15001619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women.
    Achrekar SK; Modi DN; Desai SK; Mangoli VS; Mangoli RV; Mahale SD
    Fertil Steril; 2009 Feb; 91(2):432-9. PubMed ID: 18321487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does elevated human chorionic gonadotropin alone trigger spontaneous ovarian hyperstimulation syndrome?
    Michaelson-Cohen R; Altarescu G; Beller U; Reens R; Halevy-Shalem T; Eldar-Geva T
    Fertil Steril; 2008 Nov; 90(5):1869-74. PubMed ID: 18166181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of the FSH receptor: new insights into FSH physiology.
    Meduri G; Bachelot A; Cocca MP; Vasseur C; Rodien P; Kuttenn F; Touraine P; Misrahi M
    Mol Cell Endocrinol; 2008 Jan; 282(1-2):130-42. PubMed ID: 18248882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No activating mutations of FSH receptor in four children with ovarian juvenile granulosa cell tumors and the association of these tumors with central precocious puberty.
    Bas F; Pescovitz OH; Steinmetz R
    J Pediatr Adolesc Gynecol; 2009 Jun; 22(3):173-9. PubMed ID: 19539204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyper-stimulation syndrome after spontaneous conception.
    Lussiana C; Guani B; Restagno G; Rovei V; Menato G; Revelli A; Massobrio M
    Gynecol Endocrinol; 2009 Jul; 25(7):455-9. PubMed ID: 19499413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two different entities of spontaneous ovarian hyperstimulation in a woman with FSH receptor mutation.
    Dieterich M; Bolz M; Reimer T; Costagliola S; Gerber B
    Reprod Biomed Online; 2010 Jun; 20(6):751-8. PubMed ID: 20378412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicle-stimulating hormone receptor polymorphisms in a population of infertile women.
    Falconer H; Andersson E; Aanesen A; Fried G
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):806-11. PubMed ID: 16026410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.
    Barak V; Elchalal U; Edelstein M; Kalickman I; Lewin A; Abramov Y
    Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism.
    Daelemans C; Smits G; de Maertelaer V; Costagliola S; Englert Y; Vassart G; Delbaere A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6310-5. PubMed ID: 15579795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
    Mathur R; Kailasam C; Jenkins J
    Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.